Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20508
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEkinci, Elif I-
dc.contributor.authorBarr, Elizabeth L M-
dc.contributor.authorBarzi, Federica-
dc.contributor.authorHughes, Jaquelyne T-
dc.contributor.authorLawton, Paul D-
dc.contributor.authorJones, Graham R D-
dc.contributor.authorHoy, Wendy-
dc.contributor.authorCass, Alan-
dc.contributor.authorThomas, Mark-
dc.contributor.authorSinha, Ashim-
dc.contributor.authorJerums, George-
dc.contributor.authorO'Dea, Kerin-
dc.contributor.authorMacIsaac, Richard J-
dc.contributor.authorMaple-Brown, Louise J-
dc.date2019-02-21-
dc.date.accessioned2019-04-02T01:07:33Z-
dc.date.available2019-04-02T01:07:33Z-
dc.date.issued2019-05-
dc.identifier.citationJournal of Diabetes and Its Complications 2019; 33(5): 343-349en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20508-
dc.description.abstractGlomerular hyperfiltration is not able to be detected in clinical practice. We assessed whether hyperfiltration is associated with albuminuria progression among Indigenous Australians at high risk of diabetes and kidney disease to determine its role in kidney disease progression. Longitudinal observational study of Indigenous Australians aged ≥18 years recruited from >20 sites, across diabetes and/or kidney function strata. At baseline, iohexol clearance was used to measure glomerular filtration rate (mGFR) and hyperfiltration was defined as (i) a mGFR of ≥125 mL/min/1.73 m2, and (ii) an age-adjusted definition, with the top 10% of the mGFR for each 10 year age group at baseline. Baseline and follow-up urine albumin-to-creatinine ratio (uACR) was collected, and linear regression was used to assess the associations of hyperfiltration and uACR at follow up. 407 individuals (33% men, mean age 47 years) were followed-up for a median of 3 years. At baseline, 234 had normoalbuminuria and 173 had albuminuria. Among participants with normoalbuminuria, those with mGFR ≥125 mL/min/1.73 m2 had 32% higher uACR at follow-up (p = 0.08), and those with age-adjusted hyperfiltration had 60% higher uACR (p = 0.037) compared to those who had normofiltration. These associations were independent of uACR at baseline, but attenuated by HbA1c. Associations were stronger among those without than those with albuminuria at baseline. Although not available for assessment in current clinical practice, hyperfiltration may represent a marker of subsequent albuminuria progression among individuals who have not yet developed albuminuria.en_US
dc.language.isoeng-
dc.subjectAlbuminuriaen_US
dc.subjectChronic kidney diseaseen_US
dc.subjectDiabetic kidney diseaseen_US
dc.subjectDiabetic nephropathyen_US
dc.subjectHyperfiltrationen_US
dc.subjectIndigenous Australiansen_US
dc.titleIs hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Diabetes and Its Complicationsen_US
dc.identifier.affiliationUniversity of New South Wales Sydney, Sydney, Australiaen_US
dc.identifier.affiliationSchool of Population Health, University of South Australia, Australiaen_US
dc.identifier.affiliationDepartment of Endocrinology and Diabetes, St Vincent's Hospital Melbourne and the University of Melbourne, Melbourne, Australiaen_US
dc.identifier.affiliationDiabetes and Endocrinology, Cairns Base Hospital, Cairns, Australiaen_US
dc.identifier.affiliationRoyal Perth Hospital, Perth, Australiaen_US
dc.identifier.affiliationMenzies School of Health Research, Charles Darwin University, Australiaen_US
dc.identifier.affiliationThe University of Queensland Centre for Chronic Disease, Queensland, Australiaen_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.affiliationBaker Heart and Diabetes Institute, Melbourne, Australiaen_US
dc.identifier.affiliationDivision of Medicine, Royal Darwin Hospital, Darwin, Australiaen_US
dc.identifier.affiliationSydPath, St Vincent's Hospital, Sydney, Australiaen_US
dc.identifier.doi10.1016/j.jdiacomp.2019.02.005en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-2372-395Xen_US
dc.identifier.pubmedid30904420-
dc.type.austinJournal Article-
local.name.researcherEkinci, Elif I
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on May 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.